Company Name or Ticker Symbol
Search for other Categories
Lexaria Bioscience Corp.  (LXRP)
Other Ticker:  
Price: $1.2500 $-0.04 -2.724%
Day's High: $1.32 Week Perf: 5.93 %
Day's Low: $ 1.16 30 Day Perf: -8.05 %
Volume (M): 80 52 Wk High: $ 2.43
Volume (M$): $ 100 52 Wk Avg: $1.53
Open: $1.16 52 Wk Low: $0.78

 Market Capitalization (Millions $) 95
 Shares Outstanding (Millions) 76
 Employees 4
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Lexaria Bioscience Corp.
Our company’s business plan is currently focused on the development of strategic partnerships with licensees for our patented technology in exchange for up front and/or staged licensing fees over time. Secondarily and more generally, we continue to investigate national and international opportunities for development and distribution of the Company’s enhanced functional food and supplement product offerings; to investigate expansions and additions to our intellectual property portfolio; and, to search for additional opportunities in alternative health sectors. This includes the acquisition or development of intellectual property if and when we believe it advisable to do so. We announced issuance of our first patent by the U.S. Patent and Trademark Office (USPTO) on October 26, 2016 and have received a Notice of Acceptance from the Australian Patent Office with related patent issuance date June 15 2017 No. 2015274698. We announced on November 2, 2017 a new Notice of Allowance from the USPTO that included the delivery of additional molecules such as psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatories, and nicotine all utilizing our DehydraTECHTM delivery technology. We are seeking additional patent protection for what we believe to be a unique process for the nutritional delivery of certain molecules such as cannabinoids, Nicotine, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Vitamins. To achieve sustainable and profitable growth, our company intends to control the timing and costs of our projects wherever possible.


Lexaria Bioscience's Segments

Smartfinancial Inc.

Smartfinancial Inc announced forth quarter operating profit of $6.125273 millions

Company's forth quarter earnings per share soared to $0.47 per share compared to a year ago on growing Revenue of 32.49 % to $21.83 millions.

Neos Therapeutics, Inc.

Neos Therapeutics, Inc announced forth quarter operating shortfall of $-7.237 millions

Strong Sales growth in the forth quarter, by 97.68 % to $15.39 millions helped to cut losses to $-0.22 per share, from $-0.49 in same quarter a year ago.

Gtx Inc

Redemption of Losses but Revenues Unchanged

In the forth quarter Gtx Inc decreased loss of $-0.22 per share compare to $-0.43 a year ago and improved from $-0.39 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

One Liberty Properties Inc

Top and Bottom-line Crumble

In the forth quarter One Liberty Properties Inc income fell sharply by -96.52 % of $0.01 per share compare to $0.23 a year ago and eps dropped by -98.46 % from $0.52 per share from the previous quarter.

Sales faded by -45.76 % to $20.27 millions from $37.37 millions in the same quarter a year ago and sequentially Sales increased by 3.58 % from $19.57 millions.

Cumulus Media Inc

Cumulus Media Inc recognizes $335.91 million charge

Company reports $-220.55 million loss, as impairment charges strip off $335.91 million from the forth quarter results.

You need to upgrade your Flash Player

Major Competitors Stock performance

5 Days Decrease / Increase
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

LL's Profile

Stock Price

LL's Financials

Business Description


Charts & Quotes

LL's News


LL's Competitors

Customers & Markets

Economic Indicators

LL's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071